No resume content available
PHESGO for HER2+ Breast Cancer Treatment | (pertuzumab / trastuzumab / hyaluronidase-zzfx)
Learn about PHESGO, a subcutaneous injection for HER2+ breast cancer combining PERJETA (pertuzumab) and Herceptin (trastuzumab) that's given in minutes. See Full Safety and Boxed Warnings for more information.
5 languages with 5 regional variants
